Mandate

Vinge advised Creades on its sale of shares in Lindab

Creades AB (publ) has sold 4,250,000 shares in Lindab International AB (publ) at SEK 100 per share (in total SEK 425 million) through an accelerated bookbuilt offering to institutional investors.

Vinge advised Creades. The Vinge team was headed by capital markets and public M&A partner Erik Sjöman.
 

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026